• Careers
    • Open Positions
    • Postdoctoral Training
    • Internships
    • Immigration Services
  • Contact
    • Media Inquiries
  • Intranet
La Jolla Institute for Immunology
  • Research
    • Databases
      • Database of Immune Cell Epigenomics
      • Immune Epitope Database
    • Diseases (A-Z)
    • Licensing Opportunities
    • Publications
    • Research Centers
      • Center for Autoimmunity and Inflammation
      • Center for Cancer Immunotherapy
      • Center for Vaccine Innovation
      • Center for Sex-based differences in the immune system
    • Research Services
      • Bioinformatics
      • Clinical Studies
      • Cryo-EM
      • DLAC
      • Flow Cytometry
      • Histopathology
      • Immunometabolism
      • Microscopy & Histology
      • Next Generation Sequencing
    • Legal Affairs & IP
  • Labs
    • Ay Lab
    • Benedict Lab
    • Cheroutre Lab
    • Croft Lab
    • Crotty Lab
    • Einav Lab
    • Eschweiler Lab
    • Grifoni Lab
    • Hedrick Lab
    • Hogan Lab
    • Kawakami Lab
    • Kronenberg Lab
    • Ley Lab
    • Lindestam Arlehamn Lab
    • Myers Lab
    • Peters Lab
    • Rao Lab
    • Saphire Lab
    • Schmiedel Lab
    • Schoenberger Lab
    • Sette Lab
    • Seumois Lab
    • Sharma Lab
    • Shresta Lab
    • Vijayanand Lab
    • Weiskopf Lab
  • News
    • Blog
    • Life Without Disease STORIES
    • Magazine
    • News
    • Videos
  • Events
    • Art Competition
    • Life Without Disease Event Series
    • Live from the Lab
    • Scientific Seminars
  • About Us
    • Overview
      • History
      • Institute Facts
    • Our Team
      • Leadership
      • Faculty
        • Emeriti
        • Clinical Associates
      • Board of Directors
      • Scientific Advisory Board
    • Inclusion, Diversity, Equity & Advocacy at LJI
  • Support
    • Overview
    • Ways to Give
    • SPARK Awards
    • Vanguard Giving Society
    • Planned Giving
    • Clinical Studies
    • Advancement Team
    • DONATE
  • Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
    • Media Inquiries
Support

Publications

May 30, 2023 Cell Rep.
PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion
Hope JL, Otero DC, Bae EA, Stairiker CJ, Palete AB, Faso HA, Lin M, Henriquez ML, Roy S, Seo H, Lei X, Wang ES, Chow S, Tinoco R, Daniels GA, Yip K, Campos AR, Yin J, Adams PD, Rao A, Bradley LM.
May 30, 2023 Cell Rep
Human papillomavirus e5 suppresses immunity via inhibition of the immunoproteasome and sting pathway
Miyauchi S, Kim SS, Jones RN, Zhang L, Guram K, Sharma S, Schoenberger SP, Cohen EEW, Califano JA, Sharabi AB
May 29, 2023 Cell Rep Med
Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
Tarke A, Zhang Y, Methot N, Narowski TM, Phillips E, Mallal S, Frazier A, Filaci G, Weiskopf D, Dan JM, Premkumar L, Scheuermann RH, Sette A, Grifoni A
May 12, 2023 Sci Immunol
Transcriptional programming of CD4+ TRM differentiation in viral infection balances effector- and memory-associated gene expression
Nguyen QP, Takehara KK, Deng TZ, O'Shea S, Heeg M, Omilusik KD, Milner JJ, Quon S, Pipkin ME, Choi J, Crotty S, Goldrath AW
May 9, 2023 Immunity
DNA architectural protein CTCF facilitates subset-specific chromatin interactions to limit the formation of memory CD8+ T cells
Quon S, Yu B, Russ BE, Tsyganov K, Nguyen H, Toma C, Heeg M, Hocker JD, Milner JJ, Crotty S, Pipkin ME, Turner SJ, Goldrath AW
May 7, 2023 bioRxiv
Linked CD4 + /CD8 + T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
Dolina JS, Lee J, Brightman SE, McArdle S, Hall SM, Thota RR, Lanka M, Premlal ALR, Greenbaum JA, Cohen EEW, Peters B, Schoenberger SP
May 6, 2023 Int Immunol
An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination
da Silva Antunes R, Grifoni A, Frazier A, Weiskopf D, Sette A
May 5, 2023 bioRxiv
Linked CD4 + /CD8 + T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
Joseph S Dolina, Joey Lee, Spencer E Brightman, Sara McArdle, Samantha M Hall, Rukman R Thota, Manasa Lanka, Ashmitaa Logandha Ramamoorthy Premlal, Jason A Greenbaum, Ezra E W Cohen, Bjoern Peters, Stephen P Schoenberger
May 5, 2023 Front Immunol
Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses
Westphal T, Mader M, Karsten H, Cords L, Knapp M, Schulte S, Hermanussen L, Peine S, Ditt V, Grifoni A, Addo MM, Huber S, Sette A, Lütgehetmann M, Pischke S, Kwok WW, Sidney J, Schulze Zur Wiesch J
May 1, 2023 NPJ Vaccines
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
Dijkman K, Lindenstrøm T, Rosenkrands I, Søe R, Woodworth JS, Lindestam Arlehamn CS, Mortensen R
Apr 26, 2023 Annu Rev Immunol
T cell responses to SARS-CoV-2
Sette A, Sidney J, Crotty S
Apr 25, 2023 Cell Host Microbe
Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox
Adamo S, Gao Y, Sekine T, Mily A, Wu J, Storgärd E, Westergren V, Filén F, Treutiger CJ, Sandberg JK, Sällberg M, Bergman P, Llewellyn-Lacey S, Ljunggren HG, Price DA, Ekström AM, Sette A, Grifoni A, Buggert M
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 180
  • 181
  • 182
  • Contact Us
  • Careers
  • Terms & Conditions
  • Privacy Policy
La Jolla Institute for Immunology

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2023 La Jolla Institute for Immunology. All rights reserved. LJI is a 501(c)(3) tax-exempt organization. Federal Tax ID Number 33-0328688






 

Location: